Atlas Trials

Vonoprazan-containing Triple Therapy Versus Empiric Bismuth Quadruple Therapy for First-line Helicobacter Pylori Treatment: a Randomized Clinical Trial

Clinical trial NCT05726734 · UNKNOWN

Trial details

NCT number
NCT05726734
Sponsor
Shanghai East Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Helicobacter Pylori Infection
Start date
2023-02-06
Primary completion
2025-02-06
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.